Robotic lung biopsy system under Real-World scrutiny
NCT ID NCT06923774
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This study is observing how well the Ion endoluminal system, a robotic tool, works for lung nodule biopsies and localization in everyday medical practice across Europe. Researchers will track 1,200 adults to see how often the tool correctly diagnoses lung nodules and how often complications like pneumothorax or bleeding occur. The goal is to gather real-world data, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Helios Dr. Horst Schmidt Kliniken
NOT_YET_RECRUITINGWiesbaden, 65199, Germany
Contact
-
Helios Klinikum Emil von Behring
RECRUITINGBerlin, 14165, Germany
Contact
-
Hôpital Marie Lannelongue
RECRUITINGLe Plessis-Robinson, 92350, France
Contact
-
University College London Hospitals NHS Foundation Trust
RECRUITINGLondon, NW1 2BU, United Kingdom
Contact
-
Universitätsspital Zürich
RECRUITINGZurich, 8091, Switzerland
Contact
-
Wythenshawe Hospital, Manchester University NHS Foundation Trust
RECRUITINGManchester, M23 9LT, United Kingdom
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Breathing tube-free lung surgery tested for patients with fragile lungs
- Can standard cancer treatment wake up the immune system? a study investigates.
- Quitlines may double as lung cancer screening boosters
- A mobile app aims to turn health awareness into action — a trial puts it to the test
- Text messages and chatbots may help catch lung cancer earlier in underserved communities
- Shorter radiation course may reduce side effects for lung cancer patients